Thumbnail Image
Item

UMB Researchers Test COVID-19 Vaccine Candidates

Authors
Morrison, Joanne
Advisor
Date
2020-05-06
Embargo until
Language
Book title
Publisher
Peer Reviewed
Type
Article
Video
Research Area
Jurisdiction
Collections
UMB Response to Novel Coronavirus (COVID-19)
Show all metadata
Files
Thumbnail Image
SOMTestCOVID-19VaccinemRNA_2020.05.06.pdf
Adobe PDF, 250.55 KB
Other Titles
See at
https://www.youtube.com/watch?v=HlbxzFkszZ0
Abstract
Data Availibility
Data / Code Location
Table of Contents
Description
Researchers at the University of Maryland School of Medicine (UMSOM) became the first in the United States to begin testing experimental COVID-19 vaccine candidates developed by Pfizer and BioNTech. The research, funded by Pfizer Inc., will study the safety, efficacy, and dosing of an experimental mRNA-based vaccine. Included are a news release and video describing the research.
Citations
Altmetric:
Series/Report No.
Sponsors
Rights/Terms
Keyword
Coronavirus Disease 2019 (COVID-19)
 RNA, Messenger--therapeutic use
 Vaccines
 COVID-19
 University of Maryland, Baltimore. School of Medicine
 COVID-19 (Disease)
Identifier to cite or link to this item
http://hdl.handle.net/10713/12724
Scopus Identifier
Embedded videos